Diamonds and Dogs

9/22/22

Eli Lilly (LLY) jumps 4% on an upgrade. The analyst at UBS upgraded the stock to a buy raising his price target to $363 a share. The analyst said their Mounjaro drug recently received approval as a diabetes treatment in May but expects the drug to also be used as a weight-loss remedy, which could make it one of the best-selling drugs of all time. The analyst believes the Mounjaro drug will surpass AbbVie's drug, Humira with sales over $20 billion in the coming years.

Tesla (TSLA) down 4% as the company has to recall a million vehicles due to a glitch in the power windows. What's more, none of the million-plus electric vehicles will have to go into the shop. The cars will be fixed by an over-the-air software update. If you can't get enough of Elon Musk, he is on the latest Jay Leno Garage show promoting his ambition to populate Mars.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.